AbbVie Inc. (ABBV)

Statement of Cash Flows
Quarterly Data

Difficulty: Beginner

Annual Data

Quarterly Data

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

AbbVie Inc., Consolidated Statement of Cash Flows (quarterly data)

USD $ in millions

	3 months ended	Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014		Dec 31, 2013		Sep 30, 2013		Jun 30, 2013		Mar 31, 2013
	Net earnings
	Depreciation
	Amortization of intangible assets
	Change in fair value of contingent consideration liabilities
	Stock-based compensation
	Upfront costs and milestones related to collaborations
	Devaluation loss related to Venezuela
	Intangible asset impairment
	Impacts related to U.S. tax reform
	Other, net
	Accounts receivable
	Inventories
	Prepaid expenses and other assets
	Accounts payable and other liabilities
	Changes in operating assets and liabilities
	Adjustments to reconcile net earnings to net cash from operating activities
	Cash flows from operating activities
	Acquisitions of businesses, net of cash acquired
	Other acquisitions and investments
	Acquisitions of property and equipment
	Transfers to restricted cash
	Purchases of investment securities
	Sales and maturities of investment securities
	Other
	Cash flows from investing activities
	Net change in commercial paper borrowings
	Proceeds from issuance of other short-term borrowings
	Proceeds from issuance of long-term debt
	Repayments of long-term debt and lease obligations
	Debt issuance costs
	Dividends paid
	Purchases of treasury stock
	Proceeds from the exercise of stock options
	Payments of contingent consideration liabilities
	Net transactions with Abbott Laboratories, excluding non-cash items
	Other, net
	Cash flows from financing activities
	Effect of exchange rate changes on cash and equivalents
	Net change in cash and equivalents

Source: AbbVie Inc., Quarterly and Annual Reports

Item	Description	The company
Cash flows from operating activities	The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities.	AbbVie Inc.'s cash flows from operating activities increased from Q4 2017 to Q1 2018 and from Q1 2018 to Q2 2018.

	AbbVie Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

AbbVie Inc. (ABBV)

Statement of Cash FlowsQuarterly Data

Statement of Cash Flows
Quarterly Data